What increasing impact factors mean for the RCPharm research journals The latest impact metrics from Clarivate and Scopus have been published, showing a positive trend for the Royal College of Pharmacy research journals.…
Digital systems in general practice could reduce medication errors Across the 74 randomised controlled trials under review, the most frequent intervention component was clinical decision support systems, which was mentioned in 59 papers.…
Once-weekly HIV pill performs as well as daily treatment in phase III study Researchers found that a once-weekly tablet combining islatravir and lenacapavir performed as well as the once-daily bictegravir–emtricitabine–tenofovir alafenamide regimen.…
Everything you need to know about clinical trial legislation changes Clinical trial legislation has been overhauled to speed up set-up times and include a broader range of healthcare professionals, but what do the reforms mean for patients and pharmacists?…
What the UK’s new clinical trials regime means for pharmacy practice and patient safety Pharmacists will be central to the impact of the new clinical trial regime, which is aimed to streamline regulatory timelines.…
UK signs up to European rare diseases network The National Institute for Health and Care Research said membership of the European Rare Diseases Research Alliance will open “new pathways for UK researchers to participate in international clinical trials”.…
Everything you need to know about GLP-1s for weight loss From semaglutide to tirzepatide, this article collates the latest information on pharmacological weight-loss treatments, including evidence and best practice for their use.…
Minimum age set for puberty blockers trial To participate in the ‘PATHWAYS’ clinical trial, a modified protocol has ruled that birth-registered females must be aged between 11 and 16 years, and birth-registered males must be aged between 12 and 16 years.…
Why a research mindset matters in critical care pharmacy and beyond The Royal College of Pharmacy’s chief scientist reports back on a conversation with Cathrine McKenzie, professor of intensive care pharmacy at the University of Southampton, about the contribution that practising pharmacists can make to research.…
More than half of patients who stop weight-loss drugs restart within a year Researchers found that people taking newer medications, such as tirzepatide, were 41% less likely to discontinue than those taking older drugs, such as liraglutide.…
